Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,728.00
(
-0.29%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
112.11
(
5.19%
)
Bitcoin
70,123.79
(
-1.57%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dav1234

Send PM Follow Ignore
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

dav1234

Re: DewDiligence post# 173844

Thursday, 02/06/2014 12:13:32 PM

Thursday, February 06, 2014 12:13:32 PM

Post# of 257257
Revance Therapeutics soars following IPO
After pricing its 6M-share IPO at $16, Revance Therapeutics (RVNC) opened at $21 and is now at $26.25, up 64%.The developer of novel botox products currently has a market cap of $465M
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now